Shire PLC



    Today's change

    -130.00 / -2.49%

    1 year change


    As of Sep 23 2014 17:52 BST. Data delayed by at least 15 minutes.

Search for Shire PLC and
  1. 3 hours ago

    Curbs on tax inversions fail to convince

    Dissections of a White House plan to curb tax-driven mergers gave way on Tuesday to a realisation that the most significant...

  2. 12 hours ago

    US Treasury hopes to stand logic of tax inversion deals on head

    Taxes may be one of the only two certainties, but tax benefits are very uncertain – as the US Treasury has just...

  1. September 18, 2014

    Europe struggles to catch US biotech bulls

    Boom times are back for US biotechnology. After a wobble in the spring when Janet Yellen, chairwoman of the Federal Reserve,...

  2. September 12, 2014

    Highlights from this week’s Investors Chronicle

    Buy Galliford Try (GFRD) Given the strong momentum in the housing sector and the flow of construction work, we see no reason...

  3. August 20, 2014

    What next for M&A now the bubble has burst?

    Tuesday August 5 was a bad day for all those hoping the mergers and acquisitions boom had further to run. Investment bankers...

  4. August 15, 2014

    IRS to probe Valeant tax returns after Canada deal

    A recently disclosed audit of US tax returns for Valeant, the Canadian pharmaceutical group pursuing a $53bn hostile...

  5. August 8, 2014

    Shire drops on doubt over AbbVie takeover

    All may not be lost for Shire shareholders. The drugmaker dropped 5.1 per cent this week on worries that US moves to curb...

  6. August 5, 2014

    Corporate acquirors take early aim at their target’s investors

    To win investor support for last month’s $53bn takeover of rival drugmaker Shire, AbbVie delivered a blunt message to its...

  7. July 22, 2014

    US warned of up to 25 groups eyeing foreign switch to cut tax

    Up to 25 more US companies are considering relocating overseas to cut their tax bills this year, a Democratic senator has...

  8. July 20, 2014

    Takeover deals highlight bets on equities outperforming bonds

    Hedge funds betting on the £32bn AbbVie bid for London-listed pharmaceutical company Shire, which wrapped up on Friday,...

  9. July 18, 2014

    Shire chief’s $10m ‘golden hello’ at AbbVie

    Shire’s chief executive is to receive a $10m “golden hello” after agreeing to remain with the drugmaker after its £32bn...

  10. July 18, 2014

    Shire rises as AbbVie takeover is sealed

    Investor satisfaction over dealmaking at Shire and ITV dominated the top of the FTSE 100 leaderboard as end-of-week gains...

  11. July 18, 2014

    Tax inversion risk loomed over Shire talks

    It took AbbVie two and a half months to land Shire, but on Friday the US pharmaceutical group finally sealed the £32bn deal....

  12. July 18, 2014

    AbbVie rounds on US tax laws as it snares Shire

    AbbVie defended plans to shift its tax residence to the UK after agreeing to buy Shire for £32bn and urged US politicians to...

  13. July 18, 2014

    Letter from Lex: 21st century fox

    Of course he had to get involved. Could Rupert Murdoch, one of the media sector’s most enthusiastic dealmakers, really sit...

  14. FT Alphaville

    July 18, 2014

    Inverting AbbVie into ǝıVqqA

    Over on Lex this week we’ve been pondering the finer points of what shareholders get out of tax inversions. So… from the...

  15. July 17, 2014

    AbbVie set to unveil £31bn Shire takeover

    AbbVie is set to announce its £31bn takeover of Shire, the UK speciality pharma company, as soon as Friday morning –...

  16. July 14, 2014

    Mylan in $5.3bn Abbott Laboratories deal

    US pharmaceuticals group Mylan has agreed to pay $5.3bn for the generic drugs business of Abbott Laboratories, in another...

  17. July 14, 2014

    Pharma M&A: mean inversion

    Do not drive or operate heavy machinery while trying to understand the US tax code. Shareholders in drugmakers are advised...

  18. July 14, 2014

    AbbVie/Shire - join us at 12 for a live discussion

    The above is a clause from the Medtronic/Covidien merger agreement of course – although it allows Medtronic to walk away...

  19. FT Alphaville

    July 14, 2014

    The (early) Lunch Wrap

    Good morning New York, FT ALPHAVILLE Dan had a look through the latest Quindell trading statement. The market seemed to like...

  20. July 14, 2014

    Sports Direct leads stronger FTSE 100

    Sports Direct led London’s main market benchmark higher on Monday on expectations it would announce plans to expand its...

  21. July 14, 2014

    Bid battle timeline: AbbVie’s pursuit of Shire

    How US pharmaceuticals group AbbVie sought to take over its London-listed Dublin-based rival Shire. ● May: AbbVie makes a...

  22. July 14, 2014

    AbbVie closes in on £31bn takeover of Shire

    AbbVie is closing in on a £31bn takeover of Shire in what would be the latest example of a US company buying a European...

  23. July 13, 2014

    Allergan: turnabout is fair play

    Acquisition-based growth is simply too risky. Or so Allergan keeps saying as it criticises its unrelenting suitor Valeant...

  24. July 11, 2014

    Shire in talks with US drugmaker AbbVie over £30bn bid

    Shire has opened talks with AbbVie, the US drugmaker, over its proposed £30bn takeover bid for the UK-listed speciality...

  25. July 9, 2014

    Investors press Allergan to find deal

    Shareholders in Allergan are encouraging the Botox maker to do a large acquisition of its own as it tries to fend off a...

  26. July 9, 2014

    AbbVie retraction shows panel has teeth

    Perhaps Richard Gonzalez did not make it to page 190 of the Takeover Code. The inch-thick document, written by the UK...

  27. July 9, 2014

    Five examples of the UK Takeover Code in action

    AbbVie’s statement on Wednesday was not the first time that a company has been forced to clarify its position because of the...

  28. FT Alphaville

    July 9, 2014

    Markets Live: Wednesday, 9th July, 2014

    This is the transcript of the Markets Live session ending at 11:32 on 9 Jul 2014. Participants in this session were: Paul...

  29. July 9, 2014

    Myners must give independent advice on independents

    There has been much debate over the impact that independent investment banks might have on initial public offerings. This is...

  30. July 9, 2014

    UK Takeover Panel forces AbbVie to retract claims of Shire support

    AbbVie has been forced to issue an unusual retraction a day after the US pharmaceuticals company said Shire shareholders...

  31. July 8, 2014

    AbbVie / Shire: debt and diversification

    The market does not think it will happen. AbbVie has upped its bid for Shire from £46.26 to £51.15 per share. In response,...

  32. July 8, 2014

    Airlines bounce back after Air France-KLM warns on profits

    US airlines began to climb on Wednesday after a months-long retreat, after being dragged down earlier in the day by a profit...

  33. July 8, 2014

    AbbVie lifts offer for Shire to £30bn

    AbbVie of the US has increased its offer for Shire to £30bn and urged shareholders to press the UK-listed drugmaker to enter...

  34. July 8, 2014

    AbbVie avoids Pfizer errors in bear hug against Shire

    My pals are bigger than your pals. AbbVie has resorted to an old playground intimidation tactic, by implying a majority of...

  35. July 2, 2014

    AbbVie courts shareholders to put pressure on Shire over bid

    The chief executive of AbbVie has urged Shire shareholders to press the FTSE 100 pharmaceutical group to engage with the US...

  36. June 30, 2014

    AbbVie puts investor patience in European drugmakers to the test

    Will the last mid-sized European drugmaker please turn off the lights? AbbVie’s £27bn takeover approach for UK-listed Shire...

  37. FT Alphaville

    June 30, 2014

    The (early) Lunch Wrap

    Good morning New York, FT ALPHAVILLE TWO DAYS TO GO UNTIL CAMP ALPHAVILLE! – Last chance to get your tickets for the finance...

  38. June 30, 2014

    Tax windfall pushes Shire shares to top of FTSE 100

    Shares in Shire were at the top of a steady FTSE 100 on Monday after the drugmaker pledged to use receipts of a substantial...

Search for Shire PLC and